Open AccessLoss of TSC1/TSC2 sensitizes immune checkpoint blockade in non–small cell lung cancer
Author(s) -
Qingyuan Huang,
Fei Li,
Hai Hu,
Zhaoyuan Fang,
Zhendong Gao,
Guozhan Xia,
WaiLung Ng,
Alireza KhodadadiJamayran,
Ting Chen,
Jiehui Deng,
Hua Zhang,
Christina Almonte,
Kristen Labbe,
Han Han,
Ke Geng,
Sitti Tang,
Gordon J. Freeman,
Yuan Li,
Haiquan Chen,
KwokKin Wong
Publication year - 2022
Publication title -
science advances
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.928
H-Index - 146
ISSN - 2375-2548
DOI - 10.1126/sciadv.abi9533
Subject(s) - tsc2 , tsc1 , cancer research , immune checkpoint , tumor microenvironment , kras , biology , immune system , immunotherapy , cancer , medicine , immunology , pi3k/akt/mtor pathway , signal transduction , microbiology and biotechnology , colorectal cancer , tumor cells
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom